NeoGenomics prices $275M convertible senior notes due 2032
NeoGenomics announced pricing of $275 million in 0.75% convertible senior notes maturing July 1, 2032, with an additional $41.25 million option for underwriters. The notes carry an initial conversion price of $14.16 per share, representing a 35% premium to the June 16 closing price, providing the company capital for operations and strategic initiatives.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day